ABOSEDE ASORONA HEALTH CARE LTD.
Opportunity 70/100 (strong), bankability 70/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: strategic trade sale (65/100).
Data confidence
Overall: medium (76/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Signals from accounts
Derived from iXBRL accounts · accounting standard not declaredKey financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · accounting standard unknown| Metric | 2024-10-31 | 2023-10-31 |
|---|---|---|
| Total assets | £7.0k | £-1.1k |
| Current assets | £10.0k | — |
| Net assets | £6.1k | £-2.9k |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
Recent activity
Corporate timeline (7 events)Click to expand
- 2025-11-19📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2025-11-10📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2024-10-31📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2023-07-19📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2021-10-19🏢Company incorporatedAs ABOSEDE ASORONA HEALTH CARE LTD.
- 2021-10-19➕ASORONA, Abosede appointeddirector
- 2021-10-19📄incorporation-companyincorporation · NEWINC
Owner dependency
The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.
- +Sole director: Only one active director — all governance concentrated on one person.
- +Founder name in company name: Company name contains director surname "ASORONA" — strong identity link between founder and business.
Succession & seller-readiness
Some succession indicators present. Worth watching; approach if sector/strategy fits.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
Red flags
cleanShareholders & ownership
1 active beneficial owner · dominant holder ≥75%| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Abosede Asorona Individual · Nigerian · DOB 10/1979 · age 47 | 75–100% | — | 75-100% shares | 19/10/2021 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Healthcare & medical · CR postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| 24 HOUR CARE SERVICES LTD→ 16152478 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| 247LON HEALTHCARE LIMITED→ 16882538 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| 24HR PERSONAL TRAINING LIMITED→ 10642531 · est 2017 · no financials extracted | — | — | — | — | 9y | — | — |
| 3 CEES LIMITED→ 06517695 · est 2008 · no financials extracted | — | — | — | — | 18y | — | — |
| AANN SOLUTION LTD.→ 07935445 · est 2012 · no financials extracted | — | — | — | — | 14y | — | — |
| AAP HEALTHCARE LIMITED→ 13772142 · est 2021 · no financials extracted | — | — | — | — | 4y | — | — |
| ABBEYWOOD PRACTICE LIMITED→ 10279390 · est 2016 · no financials extracted | — | — | — | — | 9y | — | — |
| ABBOTT & CO MEDICAL LIMITED→ 10631062 · est 2017 · no financials extracted | — | — | — | — | 9y | — | — |
| ABIDEQ CARE MANAGEMENT SERVICES LTD→ 07573428 · est 2011 · no financials extracted | — | — | — | — | 15y | — | — |
| ABLETRUST CARE LIMITED→ 08826464 · est 2013 · no financials extracted | — | — | — | — | 12y | — | — |
| ABYGAIL INVESTMENTS LIMITED→ 13982904 · est 2022 · no financials extracted | — | — | — | — | 4y | — | — |
| AC PHARM LIMITED→ 15617377 · est 2024 · no financials extracted | — | — | — | — | 2y | — | — |
8 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (1 active · 0 resigned)
Click a director name to see their full track record across all companies.